Génomique du cancer et du cerveau
- Research works
- 36 ▲ 16409% vs 2013–17
- Citations
- 479 13.2 per fractional work
- Top-10% rate
- 16.7% record average 16.5%
- Open access
- 73% world 28%
Not ranked overall: Génomique du cancer et du cerveau is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.7×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.7×
- Neuroscience 3.4×
- Immunology and Microbiology 2.8×
- Medicine 2.7×
- Psychology 0.5×
- Nursing 0.4×
- Health Professions 0.4×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Energy 0.3×
- Dentistry 0.1×
- Chemistry 0.1×
- Materials Science 0.0×
- Computer Science 0.0×
- Engineering 0.0×
Which keywords describe research at Génomique du cancer et du cerveau?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Lymphoma, Rituximab, Genetic Variants, Clinical Genomics, Sequence Interpretation, Neurodevelopmental Outcomes and PET Imaging.
- Radiotherapy
- Inflammation
- Genetic Mutations
- Classification
- Targeted Therapy
- Gene Expression Profiling
- Cancer
- Epidemiology
- Sequence Interpretation
- Genetic Variants
- Lymphoma
- Immunotherapy
- Clinical Genomics
- Rituximab
- Neurodevelopmental Outcomes
- PET Imaging
- Prognostic Factors
- Molecular Profiling
- Chemotherapy
- Genetic Pathogenesis
- Genomic Instability
- Brain Development
- Treatment
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 23 words, with their numbers
- Immunotherapy2▲ 9.4×11 topics
- Lymphoma2▲ 41×4 topics
- Clinical Genomics2▲ 174×1 topic
- Genetic Variants2▲ 35×3 topics
- Rituximab2▲ 41×2 topics
- Sequence Interpretation2▲ 174×1 topic
- Neurodevelopmental Outcomes2▲ 32×5 topics
- Epidemiology2▲ 1.42×20 topics
- PET Imaging2▲ 30×4 topics
- Cancer2▲ 3.6×18 topics
- Prognostic Factors2▲ 11×9 topics
- Gene Expression Profiling1▲ 54×2 topics
- Molecular Profiling1▲ 45×2 topics
- Targeted Therapy1▲ 20×4 topics
- Chemotherapy1▲ 5.9×14 topics
- Classification1▲ 9.0×1 topic
- Genetic Pathogenesis1▲ 77×1 topic
- Genetic Mutations1▲ 9.2×12 topics
- Genomic Instability1▲ 34×2 topics
- Inflammation1▲ 1.86×17 topics
- Brain Development1▲ 20×5 topics
- Radiotherapy1▲ 9.4×7 topics
- Treatment1▲ 2.8×6 topics
Which research topics does Génomique du cancer et du cerveau publish most on?
By volume in 2022–2025: Genomics and Rare Diseases, Lymphoma Diagnosis and Treatment, Retinopathy of Prematurity Studies and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Genomics and Rare Diseases Genetics 2 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 3 Retinopathy of Prematurity Studies Radiology, Nuclear Medicine and Imaging 1 works
- 4 Cancer Genomics and Diagnostics Cancer Research 1 works
- 5 Neonatal and fetal brain pathology Pediatrics, Perinatology and Child Health 1 works
- 6 Genetic factors in colorectal cancer Pathology and Forensic Medicine 1 works
- 7 RNA Research and Splicing Molecular Biology 1 works
- 8 Genomic variations and chromosomal abnormalities Genetics 1 works
- 9 Birth, Development, and Health Pediatrics, Perinatology and Child Health 1 works
- 10 Chronic Lymphocytic Leukemia Research Genetics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Génomique du cancer et du cerveau's research output changed?
Output in 2018–2022 was 16409% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rouen
- Centre Henri Becquerel
- Normandie Innovation Marché Entreprise Consommation
- Laboratoire d'Analyse des Sociétés, Transformations et Adaptations
- Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau
- Neuroendocrine, Endocrine and Germinal Differentiation Communication
- Laboratoire Sciences et Méthodes Séparatives
- Physiopathologie, autoimmunité, maladies neuromusculaire et thérapie régénératrice
- Laboratoire d'économie Rouen Normandie
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.